Clinicopathological spectrum of non-alcoholic fatty liver disease among patients in Kerala

被引:0
|
作者
Das S.K. [1 ,3 ]
Mukherjee S. [1 ]
Pandey G. [2 ]
Balakrishnan V. [2 ]
Vasudevan D.M. [1 ]
机构
[1] Department of Biochemistry, Amrita Institute of Medical Sciences, Elamakkara P.O. Cochin
[2] Department of Gastroenterology, Amrita Institute of Medical Sciences, Elamakkara P.O. Cochin
[3] Department of Biochemistry, Agartala Govt. Medical College, Agartala, West Tripura 799006, P.O. Kunjaban
关键词
Body mass index; Diabetes mellitus; Hyperlipidemia; Non-alcoholic fatty liver disease; Obesity; Waist-to-hip ratio;
D O I
10.1007/s12291-009-0028-8
中图分类号
学科分类号
摘要
Non-alcoholic fatty liver disease and its more aggressive form, non-alcoholic steatohepatitis are entities that are becoming more and more interesting to the medical community in general. A total of 93 Non-alcoholic fatty liver disease patients (64 male and 29 female) within the age range between 28 to 63 years were studied. All of them showed elevated alanine aminotransferase level (104.07 ± 56.04). Aspartate aminotransferase level (58.13 ± 31.96) was elevated more than its normal level in 82% cases and AST to ALT ratio was found 0.59 ± 0.26. Predisposing factors were diabetes mellitus (37%), obesity (13%) and hyperlipidemia (41%). In addition, 32% of the subjects were overweight.18% of the patients had elevated serum bilirubin. Our findings recommend a lower cutoff value than suggested by the World Health Organization for overweight and obesity among this racial-ethnic group. © 2009 Association of Clinical Biochemists of India.
引用
收藏
页码:155 / 158
页数:3
相关论文
共 50 条
  • [31] Non-alcoholic fatty liver disease
    Tuyama, Ana C.
    Chang, Charissa Y.
    JOURNAL OF DIABETES, 2012, 4 (03) : 266 - 280
  • [32] Non-alcoholic fatty Liver disease
    Calderaro, Julien
    Zafrani, Elie Serge
    ANNALES DE PATHOLOGIE, 2010, 30 (06) : 413 - 420
  • [33] Non-alcoholic fatty liver disease
    Farrell, Geoffrey C.
    Wardell, Rebecca
    Teoh, Narci
    Chitturi, Shiv
    INTERNAL MEDICINE JOURNAL, 2019, 49 (05) : 681 - 683
  • [34] Non-alcoholic fatty liver disease
    Adams, LA
    Angulo, P
    LIVER DISEASES: ADVANCES IN TREATMENT AND PREVENTION: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 137 : 250 - 270
  • [35] Non-Alcoholic Fatty Liver Disease
    Engin, Atilla
    OBESITY AND LIPOTOXICITY, 2017, 960 : 443 - 467
  • [36] Non-alcoholic fatty liver disease
    Brent A. Neuschwander-Tetri
    BMC Medicine, 15
  • [37] Non-alcoholic fatty liver disease
    Alba, LM
    Lindor, K
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986
  • [38] Non-alcoholic fatty liver disease
    Sattar, Naveed
    Forrest, Ewan
    Preiss, David
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [39] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
  • [40] Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients
    Goh, George Boon-Bee
    Pagadala, Mangesh R.
    Dasarathy, Jaividhya
    Unalp-Arida, Aynur
    Sargent, Ruth
    Hawkins, Carol
    Sourianarayanane, Achuthan
    Khiyami, Amer
    Yerian, Lisa
    Pai, Rish K.
    Dasarathy, Srinivasan
    McCullough, Arthur J.
    BBA CLINICAL, 2015, 3 : 141 - 145